MONTHLY ARCHIVE
March 2023 Market News Archive
9 news stories from March 2023, aggregated by Catalayer from 50+ global sources.
AIA Investment Funds - AIA Equity Income Fund Class IDQ, LU2182890538:USD historical prices - Financial Times
2023-03-31
FDA floats oncology authorization shake-up, pitching 'one-trial' model for accelerated and full approval - Fierce Biotech
2023-03-27
What’s Turo worth? - TechCrunch
2023-03-27
When the tech IPO market reopens, keep an eye on HR unicorns - TechCrunch
2023-03-22
NVIDIA, ASML, TSMC and Synopsys Set Foundation for Next-Generation Chip Manufacturing - NVIDIA Newsroom
2023-03-21
Myth-Busting: The Economy Drives the Stock Market - CFA Institute
2023-03-17
How to avoid austerity in sovereign debt crisis? - GIS Reports
2023-03-15
Europe will almost certainly avoid a recession, but huge uncertainties remain - Portfolio.hu
2023-03-10
Reata scores first FDA approval in its 21-year history, pushing rare disease drug over finish line - Fierce Pharma
2023-03-01
Ready to explore Catalayer?
Explore the platform, or bring us your next product idea.